428 related articles for article (PubMed ID: 15976035)
1. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
Blanquart C; Boute N; Lacasa D; Issad T
Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer.
Blanquart C; Gonzalez-Yanes C; Issad T
Mol Pharmacol; 2006 Nov; 70(5):1802-11. PubMed ID: 16926280
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.
Boute N; Pernet K; Issad T
Mol Pharmacol; 2001 Oct; 60(4):640-5. PubMed ID: 11562424
[TBL] [Abstract][Full Text] [Related]
4. Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum.
Issad T; Boute N; Boubekeur S; Lacasa D
Biochimie; 2005 Jan; 87(1):111-6. PubMed ID: 15733745
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the insulin receptor and Grb14: a dynamic study in living cells using BRET.
Nouaille S; Blanquart C; Zilberfarb V; Boute N; Perdereau D; Burnol AF; Issad T
Biochem Pharmacol; 2006 Nov; 72(11):1355-66. PubMed ID: 16934761
[TBL] [Abstract][Full Text] [Related]
6. Real-time measurement in living cells of insulin-like growth factor activity using bioluminescence resonance energy transfer.
Laursen LS; Oxvig C
Biochem Pharmacol; 2005 Jun; 69(12):1723-32. PubMed ID: 15935147
[TBL] [Abstract][Full Text] [Related]
7. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
8. Looking for an insulin pill? Use the BRET methodology!
Issad T; Boute N; Boubekeur S; Lacasa D; Pernet K
Diabetes Metab; 2003 Apr; 29(2 Pt 1):111-7. PubMed ID: 12746630
[TBL] [Abstract][Full Text] [Related]
9. Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer.
Blanquart C; Achi J; Issad T
Biochem Pharmacol; 2008 Oct; 76(7):873-83. PubMed ID: 18718450
[TBL] [Abstract][Full Text] [Related]
10. Development of a bioluminescence resonance energy-transfer assay for estrogen-like compound in vivo monitoring.
Michelini E; Mirasoli M; Karp M; Virta M; Roda A
Anal Chem; 2004 Dec; 76(23):7069-76. PubMed ID: 15571361
[TBL] [Abstract][Full Text] [Related]
11. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
Prinz A; Diskar M; Erlbruch A; Herberg FW
Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the insulin receptor with the receptor-like protein tyrosine phosphatases PTPalpha and PTPepsilon in living cells.
Lacasa D; Boute N; Issad T
Mol Pharmacol; 2005 Apr; 67(4):1206-13. PubMed ID: 15630078
[TBL] [Abstract][Full Text] [Related]
13. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer.
Tan PK; Wang J; Littler PL; Wong KK; Sweetnam TA; Keefe W; Nash NR; Reding EC; Piu F; Brann MR; Schiffer HH
Mol Pharmacol; 2007 Dec; 72(6):1440-6. PubMed ID: 17715395
[TBL] [Abstract][Full Text] [Related]
14. Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET).
Kim YP; Jin Z; Kim E; Park S; Oh YH; Kim HS
Biochem Biophys Res Commun; 2009 May; 382(3):530-4. PubMed ID: 19289109
[TBL] [Abstract][Full Text] [Related]
15. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
17. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of bioluminescence-based resonance energy transfer methods for monitoring of proteolytic cleavage.
Dacres H; Dumancic MM; Horne I; Trowell SC
Anal Biochem; 2009 Feb; 385(2):194-202. PubMed ID: 19026607
[TBL] [Abstract][Full Text] [Related]
19. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer.
Schiffer HH; Reding EC; Fuhs SR; Lu Q; Piu F; Wong S; Littler PL; Weiner DM; Keefe W; Tan PK; Nash NR; Knapp AE; Olsson R; Brann MR
Mol Pharmacol; 2007 Feb; 71(2):508-18. PubMed ID: 16968809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
